Browsing by Author Lalezari, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 4 to 6 of 6 < previous 
TitleAuthor(s)Issue DateViews
 
Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients
Proceeding/Conference:Journal of Hepatology
Ma, XLLalezari, JNguyuen, TBae, HoSchiff, ERFung, SYuen, RMFHassanein, THann, HWElkhashab, MDieterich, DSulkowski, MKwo, PNahass, RAgarwal, KRamji, APark, JRavendhran, NChan, SWeilert, FHan, SHAyoub, WGane, EJacobson, IBennett, MHuang, QYan, RHuey, VRuby, ELiaw, SColonno, RLopatin, U
2019
 
Safety, tolerability, pharmacokinetics and antiviral activity of AL-3778, a first-in-class, HBV core assembly modulator alone and in combination with peginterferon-alpha 2A, in treatment naive HBeAg-positive chronic hepatitis B patients
Proceeding/Conference:Hepatology International
Kennedy, WYuen, RMFKim, DJWeilert, FChan, HLYLalezari, JHwang, SGNguyen, TWestland, CKakuda, TBrown, NKlumpp, KFlores, LTalloen, WLenz, OGane, Evan Remoortere, PChandra, SFry, J
2017
116
 
Viral response and safety following discontinuation of treatment with the core inhibitor vebicorvir and a nucleos (t)ide reverse transcriptase inhibitor in patients with HBeAg positive or negative chronic hepatitis B virus infection
Proceeding/Conference:Journal of Hepatology
Gane, ESulkowskI, MMa, XNguyen, THann, HWHassanein, TElkhashab, MChan, SNahass, RBennett, MPark, JJacobson, IBonacini, MMa, JYan, RKnox, SJStamm, LRamji, AHan, SHBAyoub, WRavendhran, NKwo, PYDieterich, DBae, HSchiff, ERLalezari, JFung, SYuen, RMF
2021
Showing results 4 to 6 of 6 < previous